{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:54:02Z","timestamp":1781873642257,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00038"],"award-info":[{"award-number":["PI22\/00038"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IN607D2023\/05"],"award-info":[{"award-number":["IN607D2023\/05"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Linezolid commonly causes hematologic toxicity, especially thrombocytopenia, during extended treatment. This effect is linked to the inhibition of mitochondrial protein synthesis, which impairs oxidative phosphorylation and cellular energy production. Although reduced complex IV activity has been observed in long-term therapy, the connection between treatment duration and mitochondrial dysfunction in humans remains insufficiently defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Forty patients were included and stratified by treatment duration: 2\u20137 days (group 1), 8\u201314 days (group 2) and more than 14 days (group 3). To evaluate mitochondrial function in peripheral blood mononuclear cells (PBMCs) from patients treated with linezolid for different durations, Seahorse XF was used. To assess protein expression changes associated with mitochondrial toxicity, LC-MS\/MS was used. Differentially expressed proteins were identified in R based on fold-change thresholds (|log\u2082FC|\u22650.58) and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05, and results were visualized with volcano plots and STRING interaction networks.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All the groups were similar in terms of variables and characteristics. Mitochondrial respiration declined progressively with treatment duration and platelet counts showed a parallel reduction. Proteomic analysis identified one cluster of downregulated protein in group 2 of patients and two in group 3; they were involved in mitochondrial ATP synthesis\u2014mainly subunits of complexes I and IV of the respiratory chain\u2014supporting a concordant functional and molecular pattern of mitochondrial impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prolonged linezolid treatment was associated with progressive mitochondrial dysfunction, as reflected by both functional assays and proteomic profiles. Concordant changes in respiration and protein expression support mitochondrial involvement in linezolid-related toxicity and suggest that, in addition to previously reported alterations in complex IV, complex I proteins may also be affected in treated patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08406-5","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:46:07Z","timestamp":1781012767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prolonged linezolid therapy induces progressive mitochondrial dysfunction in human peripheral blood mononuclear cells"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3457-0613","authenticated-orcid":false,"given":"Marta","family":"Mart\u00ednez-Guiti\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2996-8405","authenticated-orcid":false,"given":"Francisco","family":"Cajade-Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5281-5694","authenticated-orcid":false,"given":"Diana Carolina","family":"Castro-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3717-5693","authenticated-orcid":false,"given":"Andrea","family":"Cuartero-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-9930","authenticated-orcid":false,"given":"Rub\u00e9n","family":"Nogueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1995-5016","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Fern\u00e1ndez-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4798-7730","authenticated-orcid":false,"given":"Sonia","family":"Molinos-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8917-5525","authenticated-orcid":false,"given":"Ignacio","family":"Ortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0835-034X","authenticated-orcid":false,"given":"Irene","family":"Zarra-Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8231-7831","authenticated-orcid":false,"given":"Miguel","family":"Gonz\u00e1lez-Barcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7348-7337","authenticated-orcid":false,"given":"Anxo","family":"Fern\u00e1ndez-Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8555-1415","authenticated-orcid":false,"given":"Cristina","family":"Mondelo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"6","key":"8406_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s40262-022-01125-2","volume":"61","author":"E Band\u00edn-Vilar","year":"2022","unstructured":"Band\u00edn-Vilar E, Garc\u00eda-Quintanilla L, Castro-Balado A, Zarra-Ferro I, Gonz\u00e1lez-Barcia M, Campos-Toimil M, et al. A Review of Population Pharmacokinetic Analyses of Linezolid. Clin Pharmacokinet. 2022 Jun;61(6):789\u2013817.","journal-title":"Clin Pharmacokinet Jun"},{"key":"8406_CR2","doi-asserted-by":"publisher","first-page":"1338902","DOI":"10.3389\/fphar.2024.1338902","volume":"15","author":"F Zou","year":"2024","unstructured":"Zou F, Cui Z, Lou S, Ou Y, Zhu C, Shu C, et al. Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database. Front Pharmacol. 2024;15:1338902.","journal-title":"Front Pharmacol"},{"issue":"8","key":"8406_CR3","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1128\/AAC.46.8.2723-2726.2002","volume":"46","author":"SL Gerson","year":"2002","unstructured":"Gerson SL, Kaplan SL, Bruss JB, Le V, Arellano FM, Hafkin B, et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother. 2002 Aug;46(8):2723\u20136.","journal-title":"Antimicrob Agents Chemother Aug"},{"issue":"3","key":"8406_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/17512433.2023.2181160","volume":"16","author":"D Cattaneo","year":"2023","unstructured":"Cattaneo D, Marriott DJ, Gervasoni C. Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations. Expert Rev Clin Pharmacol. 2023 Mar;16(3):219\u201330.","journal-title":"Expert Rev Clin Pharmacol Mar"},{"issue":"9","key":"8406_CR5","first-page":"e00542","volume":"61","author":"G Garrabou","year":"2017","unstructured":"Garrabou G, Soriano \u00c0, Pin\u00f3s T, Casanova-Moll\u00e0 J, Pacheu-Grau D, Mor\u00e9n C, et al. Influence of mitochondrial genetics on the mitochondrial toxicity of linezolid in blood cells and skin nerve fibers. Antimicrob Agents Chemother. 2017 Sep;61(9):e00542\u201317.","journal-title":"Antimicrob Agents Chemother Set"},{"issue":"5","key":"8406_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1302\/2058-5241.2.160063","volume":"2","author":"H Winkler","year":"2017","unstructured":"Winkler H. Treatment of chronic orthopaedic infection. EFORT Open Rev. 2017 May;2(5):110\u20136.","journal-title":"EFORT Open Rev May"},{"issue":"7","key":"8406_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1302\/2058-5241.4.180092","volume":"4","author":"P Izakovicova","year":"2019","unstructured":"Izakovicova P, Borens O, Trampuz A. Periprosthetic joint infection: current concepts and outlook. EFORT Open Rev. 2019 Jul;4(7):482\u201394.","journal-title":"EFORT Open Rev Jul"},{"issue":"2","key":"8406_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1183\/09031936.00009509","volume":"34","author":"GB Migliori","year":"2009","unstructured":"Migliori GB, Eker B, Richardson MD, Sotgiu G, Zellweger JP, Skrahina A, et al. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur Respir J. 2009 Aug;34(2):387\u201393.","journal-title":"Eur Respir J Aug"},{"key":"8406_CR9","doi-asserted-by":"crossref","unstructured":"Margalit I, Lebeaux D, Tishler O, Goldberg E, Bishara J, Yahav D, et al. How do I manage nocardiosis? Clin Microbiol Infect. 2021 Apr;27(4):550\u20138.","DOI":"10.1016\/j.cmi.2020.12.019"},{"issue":"11","key":"8406_CR10","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1093\/jac\/dkad276","volume":"78","author":"K Veerman","year":"2023","unstructured":"Veerman K, Goosen J, Spijkers K, Jager N, Heesterbeek P, Telgt D. Prolonged use of linezolid in bone and joint infections: a retrospective analysis of adverse effects. J Antimicrob Chemother. 2023 Nov;78(11):2660\u20136.","journal-title":"J Antimicrob Chemother Nov"},{"issue":"1","key":"8406_CR11","first-page":"3","volume":"44","author":"RZ Zhao","year":"2019","unstructured":"Zhao RZ, Jiang S, Zhang L, Yu ZB. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int J Mol Med. 2019 Jul;44(1):3\u201315.","journal-title":"Int J Mol Med Jul"},{"issue":"21","key":"8406_CR12","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJM200511243532123","volume":"353","author":"A Soriano","year":"2005","unstructured":"Soriano A, Mir\u00f3 O, Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med. 2005 Nov;353(21):2305\u20136.","journal-title":"N Engl J Med Nov"},{"issue":"3","key":"8406_CR13","first-page":"e01599","volume":"62","author":"TV Milosevic","year":"2018","unstructured":"Milosevic TV, Payen VL, Sonveaux P, Muccioli GG, Tulkens PM, Van Bambeke F. Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism, and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically Relevant Concentrations in Cultured Human HL-60 Promyelocytes and THP-1 Monocytes. Antimicrob Agents Chemother. 2018 Mar;62(3):e01599\u201317.","journal-title":"Antimicrob Agents Chemother Mar"},{"issue":"5","key":"8406_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijantimicag.2019.07.021","volume":"54","author":"TV Milosevic","year":"2019","unstructured":"Milosevic TV, Vertenoeil G, Payen VL, Sonveaux P, Tulkens PM, Constantinescu SN, et al. Prolonged inhibition and incomplete recovery of mitochondrial function in oxazolidinone-treated megakaryoblastic cell lines. Int J Antimicrob Agents. 2019 Nov;54(5):661\u20137.","journal-title":"Int J Antimicrob Agents Nov"},{"issue":"3","key":"8406_CR15","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1128\/AAC.01190-06","volume":"51","author":"G Garrabou","year":"2007","unstructured":"Garrabou G, Soriano A, L\u00f3pez S, Guallar JP, Giralt M, Villarroya F, et al. Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother. 2007 Mar;51(3):962\u20137.","journal-title":"Antimicrob Agents Chemother Mar"},{"issue":"9","key":"8406_CR16","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/INF.0b013e3182186035","volume":"30","author":"E Su","year":"2011","unstructured":"Su E, Crowley K, Carcillo JA, Michaels MG. Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children. Pediatr Infect Dis J. 2011 Sep;30(9):804\u20136.","journal-title":"Pediatr Infect Dis J Set"},{"issue":"2","key":"8406_CR17","first-page":"147","volume":"17","author":"J Casanova-Molla","year":"2012","unstructured":"Casanova-Molla J, Morales M, Garrabou G, Sol\u00e0-Valls N, Soriano A, Calvo M, et al. Mitochondrial loss indicates early axonal damage in small fiber neuropathies. J Peripher Nerv Syst JPNS. 2012 Jun;17(2):147\u201357.","journal-title":"J Peripher Nerv Syst JPNS Jun"},{"issue":"7","key":"8406_CR18","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1055\/a-1690-8897","volume":"122","author":"N Letunica","year":"2022","unstructured":"Letunica N, Van Den Helm S, McCafferty C, Swaney E, Cai T, Attard C, et al. Proteomics in Thrombosis and Hemostasis. Thromb Haemost. 2022 Jul;122(7):1076\u201384.","journal-title":"Thromb Haemost Jul"},{"issue":"9","key":"8406_CR19","first-page":"942","volume":"13","author":"PE Geyer","year":"2017","unstructured":"Geyer PE, Holdt LM, Teupser D, Mann M. Revisiting biomarker discovery by plasma proteomics. Mol Syst Biol. 2017 Sep;13(9):942.","journal-title":"Mol Syst Biol Set"},{"issue":"2","key":"8406_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/jcm9020311","volume":"9","author":"A Alfatni","year":"2020","unstructured":"Alfatni A, Riou M, Charles AL, Meyer A, Barnig C, Andres E, et al. Peripheral blood mononuclear cells and platelets mitochondrial dysfunction, oxidative stress, and circulating mtDNA in cardiovascular diseases. J Clin Med. 2020 Jan;9(2):311.","journal-title":"J Clin Med Jan"},{"key":"8406_CR21","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.2147\/IDR.S408102","volume":"16","author":"L Zhang","year":"2023","unstructured":"Zhang L, Yan Y, Liao R, Dong H. Effect of platelet parameters on linezolid-related thrombocytopenia in hospitalized patients. Infect Drug Resist. 2023;16:6145\u201354.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"8406_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/NRL.0000000000000084","volume":"21","author":"I Vodopivec","year":"2016","unstructured":"Vodopivec I, Cho TA, Rizzo JF, Frosch MP, Sims KB. Mitochondrial encephalopathy and optic neuropathy due to m.10158 MT-ND3 complex I mutation presenting in an adult patient: case report and review of the literature. Neurologist. 2016 Jul;21(4):61\u20135.","journal-title":"Neurologist Jul"},{"issue":"4","key":"8406_CR23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.46497\/ArchRheumatol.2022.9168","volume":"37","author":"X Huang","year":"2022","unstructured":"Huang X, Yan P, Song X, Zhang S, Deng Y, Huang C, et al. MT-CO1 expression in nine organs and tissues of different-aged MRL\/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis. Arch Rheumatol. 2022 Dec;37(4):504\u201316.","journal-title":"Arch Rheumatol Dec"},{"issue":"1","key":"8406_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10529-018-2614-4","volume":"41","author":"W Zhang","year":"2019","unstructured":"Zhang W, Wang Y, Wan J, Zhang P, Pei F. COX6B1 relieves hypoxia\/reoxygenation injury of neonatal rat cardiomyocytes by regulating mitochondrial function. Biotechnol Lett. 2019 Jan;41(1):59\u201368.","journal-title":"Biotechnol Lett Jan"},{"issue":"5","key":"8406_CR25","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ajhg.2012.09.016","volume":"91","author":"A Indrieri","year":"2012","unstructured":"Indrieri A, van Rahden VA, Tiranti V, Morleo M, Iaconis D, Tammaro R, et al. Mutations in COX7B cause microphthalmia with linear skin lesions, an unconventional mitochondrial disease. Am J Hum Genet. 2012 Nov;91(5):942\u20139.","journal-title":"Am J Hum Genet Nov"},{"key":"8406_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sbi.2020.01.004","volume":"63","author":"K Parey","year":"2020","unstructured":"Parey K, Wirth C, Vonck J, Zickermann V. Respiratory complex I - structure, mechanism and evolution. Curr Opin Struct Biol. 2020 Aug;63:1\u20139.","journal-title":"Curr Opin Struct Biol Aug"},{"issue":"11","key":"8406_CR27","first-page":"296","volume":"10","author":"QCL Dang","year":"2020","unstructured":"Dang QCL, Phan DH, Johnson AN, Pasapuleti M, Alkhaldi HA, Zhang F, et al. Analysis of Human Mutations in the Supernumerary Subunits of Complex I. Life Basel Switz. 2020 Nov;10(11):296.","journal-title":"Life Basel Switz Nov"},{"issue":"1","key":"8406_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41467-024-55768-9","volume":"16","author":"Y Yi","year":"2025","unstructured":"Yi Y, Wang G, Zhang W, Yu S, Fei J, An T, et al. Mitochondrial-cytochrome C oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation. Nat Commun. 2025 Jan;16(1):212.","journal-title":"Nat Commun Jan"},{"issue":"1","key":"8406_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41419-024-06443-w","volume":"15","author":"S Liu","year":"2024","unstructured":"Liu S, Shao F, Wang Y, Zhang Y, Yu H, Zhang N, et al. COX6C expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma. Cell Death Dis. 2024 Jan;15(1):74.","journal-title":"Cell Death Dis Jan"},{"issue":"7","key":"8406_CR30","doi-asserted-by":"publisher","first-page":"148414","DOI":"10.1016\/j.bbabio.2021.148414","volume":"1862","author":"E Fern\u00e1ndez-Vizarra","year":"2021","unstructured":"Fern\u00e1ndez-Vizarra E, L\u00f3pez-Calcerrada S, Formosa LE, P\u00e9rez-P\u00e9rez R, Ding S, Fearnley IM, et al. SILAC-based complexome profiling dissects the structural organization of the human respiratory supercomplexes in SCAFIKO cells. Biochim Biophys Acta Bioenerg. 2021 Jul;1862(7):148414.","journal-title":"Biochim Biophys Acta Bioenerg Jul"},{"issue":"1","key":"8406_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1134\/S0006297921010041","volume":"86","author":"D Rotko","year":"2021","unstructured":"Rotko D, Kudin AP, Zsurka G, Kulawiak B, Szewczyk A, Kunz WS. Molecular and Functional Effects of Loss of Cytochrome C Oxidase Subunit 8A. Biochem Biokhimiia. 2021 Jan;86(1):33\u201343.","journal-title":"Biochem Biokhimiia Jan"},{"issue":"6","key":"8406_CR32","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/humu.23210","volume":"38","author":"F Baertling","year":"2017","unstructured":"Baertling F, Al-Murshedi F, S\u00e1nchez-Caballero L, Al-Senaidi K, Joshi NP, Venselaar H, et al. Mutation in mitochondrial complex IV subunit COX5A causes pulmonary arterial hypertension, lactic acidemia, and failure to thrive. Hum Mutat. 2017 Jun;38(6):692\u2013703.","journal-title":"Hum Mutat Jun"},{"issue":"21","key":"8406_CR33","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.devcel.2021.10.008","volume":"56","author":"S Krishna","year":"2021","unstructured":"Krishna S, Arrojo E, Drigo R, Capitanio JS, Ramachandra R, Ellisman M, Hetzer MW. Identification of long-lived proteins in the mitochondria reveals increased stability of the electron transport chain. Dev Cell. 2021 Nov;56(21):2952\u2013e29659.","journal-title":"Dev Cell Nov"},{"key":"8406_CR34","doi-asserted-by":"publisher","first-page":"102095","DOI":"10.1016\/j.mito.2025.102095","volume":"86","author":"O Ugarteburu","year":"2025","unstructured":"Ugarteburu O, Farr\u00e9-Tarrats L, Mu\u00f1oz-Pujol G, Unceta M, Las Heras JD, Garc\u00eda-Ribes A, et al. Complex IV deficiency due to COX4I1 deep intronic and de novo variants results in progressive motor impairment and Leigh syndrome. Mitochondrion. 2025 Nov;86:102095.","journal-title":"Mitochondrion Nov"},{"issue":"41","key":"8406_CR35","doi-asserted-by":"publisher","first-page":"43363","DOI":"10.18632\/oncotarget.6222","volume":"6","author":"SP Gao","year":"2015","unstructured":"Gao SP, Sun HF, Jiang HL, Li LD, Hu X, Xu XE, et al. Loss of COX5B inhibits proliferation and promotes senescence via mitochondrial dysfunction in breast cancer. Oncotarget. 2015 Dec;6(41):43363\u201374.","journal-title":"Oncotarget Dec"},{"key":"8406_CR36","doi-asserted-by":"publisher","first-page":"111340","DOI":"10.1016\/j.cellsig.2024.111340","volume":"122","author":"Q Fu","year":"2024","unstructured":"Fu Q, Lv R, Wang S, Wang W, Li Y, Qiu G, et al. NDUFA8 promotes white fat Browning by improving mitochondrial respiratory chain complex I function to ameliorate obesity by in vitro and in vivo. Cell Signal. 2024 Oct;122:111340.","journal-title":"Cell Signal Oct"},{"issue":"7623","key":"8406_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature19754","volume":"538","author":"DA Stroud","year":"2016","unstructured":"Stroud DA, Surgenor EE, Formosa LE, Reljic B, Frazier AE, Dibley MG, et al. Accessory subunits are integral for assembly and function of human mitochondrial complex I. Nat. 2016 Oct;538(7623):123\u20136.","journal-title":"Nat Oct"},{"issue":"23","key":"8406_CR38","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.1111\/febs.15714","volume":"288","author":"R Pamplona","year":"2021","unstructured":"Pamplona R, Jov\u00e9 M, Mota-Martorell N, Barja G. Is the NDUFV2 subunit of the hydrophilic complex I domain a key determinant of animal longevity? FEBS J. 2021 Dec;288(23):6652\u201373.","journal-title":"FEBS J Dec"},{"issue":"9","key":"8406_CR39","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1093\/jac\/dkt133","volume":"68","author":"Y Nukui","year":"2013","unstructured":"Nukui Y, Hatakeyama S, Okamoto K, Yamamoto T, Hisaka A, Suzuki H, et al. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia. J Antimicrob Chemother. 2013 Sep;68(9):2128\u201333.","journal-title":"J Antimicrob Chemother Set"},{"issue":"6","key":"8406_CR40","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s15010-014-0674-5","volume":"42","author":"B Natsumoto","year":"2014","unstructured":"Natsumoto B, Yokota K, Omata F, Furukawa K. Risk factors for linezolid-associated thrombocytopenia in adult patients. Infect. 2014 Dec;42(6):1007\u201312.","journal-title":"Infect Dec"},{"key":"8406_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/B978-0-12-801415-8.00016-3","volume":"547","author":"AS Divakaruni","year":"2014","unstructured":"Divakaruni AS, Paradyse A, Ferrick DA, Murphy AN, Jastroch M. Analysis and interpretation of microplate-based oxygen consumption and pH data. Methods Enzymol. 2014;547:309\u201354.","journal-title":"Methods Enzymol"},{"issue":"12","key":"8406_CR42","first-page":"1424","volume":"117","author":"DF Wilson","year":"2014","unstructured":"Wilson DF, Harrison DK, Vinogradov A. Mitochondrial cytochrome c oxidase and control of energy metabolism: measurements in suspensions of isolated mitochondria. J Appl Physiol Bethesda Md 1985. 2014 Dec;117(12):1424\u201330.","journal-title":"J Appl Physiol Bethesda Md 1985 Dec"},{"issue":"6","key":"8406_CR43","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1128\/AAC.01411-05","volume":"50","author":"EE McKee","year":"2006","unstructured":"McKee EE, Ferguson M, Bentley AT, Marks TA. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother. 2006 Jun;50(6):2042\u20139.","journal-title":"Antimicrob Agents Chemother Jun"},{"issue":"4","key":"8406_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1046\/j.1471-4159.2003.01508.x","volume":"84","author":"S Mottin","year":"2003","unstructured":"Mottin S, Laporte P, Cespuglio R. Inhibition of NADH oxidation by chloramphenicol in the freely moving rat measured by picosecond time-resolved emission spectroscopy. J Neurochem. 2003 Feb;84(4):633\u201342.","journal-title":"J Neurochem Feb"},{"key":"8406_CR45","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-biochem-070511-103700","volume":"82","author":"J Hirst","year":"2013","unstructured":"Hirst J. Mitochondrial complex I. Annu Rev Biochem. 2013;82:551\u201375.","journal-title":"Annu Rev Biochem"},{"issue":"47","key":"8406_CR46","doi-asserted-by":"publisher","first-page":"18934","DOI":"10.1073\/pnas.1319247110","volume":"110","author":"B Andrews","year":"2013","unstructured":"Andrews B, Carroll J, Ding S, Fearnley IM, Walker JE. Assembly factors for the membrane arm of human complex I. Proc Natl Acad Sci U S A. 2013 Nov;110(47):18934\u20139.","journal-title":"Proc Natl Acad Sci U S Nov"},{"issue":"5","key":"8406_CR47","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.febslet.2011.01.046","volume":"585","author":"R Szklarczyk","year":"2011","unstructured":"Szklarczyk R, Wanschers BFJ, Nabuurs SB, Nouws J, Nijtmans LG, Huynen MA. NDUFB7 and NDUFA8 are located at the intermembrane surface of complex I. FEBS Lett. 2011 Mar;585(5):737\u201343.","journal-title":"FEBS Lett March"},{"issue":"10","key":"8406_CR48","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.tcb.2018.06.006","volume":"28","author":"K Fiedorczuk","year":"2018","unstructured":"Fiedorczuk K, Sazanov LA. Mammalian mitochondrial complex I structure and disease-causing mutations. Trends Cell Biol. 2018 Oct;28(10):835\u201367.","journal-title":"Trends Cell Biol Oct"},{"issue":"1","key":"8406_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/bjo.2006.102541","volume":"91","author":"M Javaheri","year":"2007","unstructured":"Javaheri M, Khurana RN, O\u2019hearn TM, Lai MM, Sadun AA. Linezolid-induced optic neuropathy: A mitochondrial disorder? Br J Ophthalmol. 2007 Jan;91(1):111\u20135.","journal-title":"Br J Ophthalmol Jan"},{"issue":"10","key":"8406_CR50","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/life15101587","volume":"15","author":"CM Esenulku","year":"2025","unstructured":"Esenulku CM, Cicek I, Somuncu AM, Yavuzer B, Sezgin ET, Tastan TB, et al. Protective effect of exogenous adenosine triphosphate against ocular toxicity of linezolid in rats. Life. 2025;15(10):1587.","journal-title":"Life"},{"issue":"2","key":"8406_CR51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/ph19020341","volume":"19","author":"HB Ozgodek","year":"2026","unstructured":"Ozgodek HB, Ince R, Kahramanlar AA, Yavuzer B, Sezgin ET, Mammadov R, et al. A comparative evaluation of the therapeutic effects of adenosine triphosphate, coenzyme Q10, pyridoxine, and thiamine pyrophosphate in a linezolid-induced peripheral neuropathic pain model in rats. Pharmaceuticals. 2026;19(2):341.","journal-title":"Pharmaceuticals"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08406-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:04:07Z","timestamp":1781870647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08406-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8406"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08406-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice. The study protocol was approved by the Ethics Committee of Galicia, Spain (Protocol Code: 2023\/048). Written informed consent was obtained from all subjects involved in the study prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"789"}}